Top

Published in:

01-04-2012 | Upper Respiratory, Head, and Neck Infections (I Brook, Section Editor)

Effects of Active and Passive Smoking on Ear Infections

Authors: Gonca Yilmaz, Nilgun Demirli Caylan, Can Demir Karacan

Published in: Current Infectious Disease Reports | Issue 2/2012

Abstract

Otitis media (OM) is one of the most frequent diseases in young children, causing to visit a physician, and also the most common indication for antibiotic prescription. The peak incidence and prevalence of OM is 6 to 18 months of age. In children, second-hand smoke (SHS) exposure is associated with upper and lower respiratory tract infections, such as acute otitis media (AOM), pneumonia, and bronchitis. Despite the overwhelming evidence of the role of SHS exposure on infant health, a very high proportion of children still continue to be exposed. This important relationship between all kinds of smoking and poor health may not be appreciated universally. With this article, we aim to review tobacco smoke exposure and OM connection. How this exposure may cause OM especially in young children? What can be done to prevent and to reduce the harmfull effects of tobacco smoking?

Forgie S, Zhanel G, Robinson J. Canadian paediatric society, infectious diseases and immunization committee: antibiotic management of acute otitis media. Paediatr Child Health. 1998;3:265–7.

Marra F, Patrick DM, Chong M, Bowie WR. Antibiotic use among children in British Columbia, Canada. J Antimicrob Chemother. 2006;58:830–9.PubMedCrossRef

Kerschner JE. Otitis media. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. Philadelphia: Saunders Elsevier; 2007. p. 2632–46.

Engel J, Anteunis L, Volovics A, et al. Prevalence rates of otitis media with effusion from 0 to 2 years of age: healthy-born versus high-risk-born infants. Int J Pediatr Otorhinolaryngol. 1999;47:243–51.PubMedCrossRef

Engel JA, Straetemans M, Zielhuis GA. Birth characteristics and recurrent otitis media with effusion in young children. Int J Pediatr Otorhinolaryngol. 2005;69:533–40.PubMedCrossRef

Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16:979–83.PubMedCrossRef

Nuorti JP, Butler JC, Farley MM. Active bacterial core surveillance team: cigarette smoking and invasive pneumococcal disease. N Engl J Med. 2000;342:681–9.PubMedCrossRef

Bakoula CG, Kafritsa YJ, Kavadias GD, et al. Objective passive-smoking indicators and respiratory morbidity in young children. Lancet. 1995;346:280–1.PubMedCrossRef

DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children’s health. Pediatrics. 2004;113:1007–15.PubMed

10.

Ey JL, Holberg CJ, Aldous MB, et al. Passive smoking exposure and otitis media in the first year of life. Pediatrics. 1995;95:670–7.PubMed

11.

Adair-Bischoff CE, Sauve RS. Environmental tobacco smoke and middle ear disease in preschool-age children. Arch Pediatr Adolesc Med. 1998;152:127–33.PubMed

12.

Lanari M, Giovannini M, Giuffre L, et al. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol. 2002;33:458–65.PubMedCrossRef

13.

Strachan DP, Cook DG. Health effects of passive smoking: 1-Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997;52:905–14.PubMedCrossRef

14.

WHO report on the global tobacco epidemic: Warning about the dangers of tobacco. World Health Organization 2011. Available at: http://www.who.int/tobacco/global_report/2011/en/index.html. Accessed October 2011

15.

WHO report on the global tobacco epidemic: Implementing smokefree environments. Geneva, World Health Organization, 2009. Available at: http://www.who.int/tobacco/mpower/2009/gtcr_download/en/index.html Accessed October 2011.

16.

Gender, women, and the tobacco epidemic. World Heath Organization, 2010. Available at http://www.who.int/tobacco/publications/gender/women_tob_epidemic/en/index.html Accessed October 2011.

17.

Aligne CA, Stoddard JJ. Tobacco and children: an economic evaluation of the medical effects of parental smoking. Arch Pediatr Adolesc Med. 1997;151(7):648–53.PubMedCrossRef

18.

The Global Youth Tobacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tob Control. 2002;11:252–70.CrossRef

19.

Tanski SE, Prokhorov AV, Klein JD. Youth and tobacco. Minerva Pediatr. 2004;56:553–65.PubMed

20.

Sargent JD, Beach ML, Adachi-Mejia AM, et al. Exposure to movie smoking: its relation to smoking initiation among US adolescents. Pediatrics. 2005;116(5):1183–91.PubMedCrossRef

21.

Hill KG, Hawkins JD, Catalano RF, et al. Family influences on the risk of daily smoking initiation. J Adolesc Health. 2005;37(3):202–10.PubMedCrossRef

22.

Leatherdale ST, Brown KS, Cameron R, Mc-Donald PW. Social modeling in the school environment, student characteristics, and smoking susceptibility: a multi-level analysis. J Adolesc Health. 2005;37(4):330–6.PubMedCrossRef

23.

Soliman S, Pollack HA, Warner KE. Decrease in the prevalence of environmental tobacco smoke exposure in the home during the 1990s in families with children. Am J Public Health. 2004;94(2):314–20.PubMedCrossRef

24.

Coghlin J, Hammond SK, Gann PH. Development of epidemiologic tools for measuring environmental tobacco smoke exposure. Am J Epidemiol. 1989;130:696–704.PubMed

25.

Lynch CJ. Half of selected tobacco smoke markers. Eur J Respir. 1984;65(suppl):63–7.

26.

Greenberg RA, Haley NJ, Etzel RA, et al. Measuring the exposure of infants to tobacco smoke: nicotine and cotinine in urine and saliva. N Eng J Med. 1984;310:1075–8.CrossRef

27.

Eliopoulos C, Klein J, Phan MK, et al. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA. 1994;271:621–3.PubMedCrossRef

28.

Hengen N, Hengen M. Gas–liquid chromatographic determination of nicotine and cotinine in plasma. Clin Chem. 1978;24(1):50–3.PubMed

29.

Feyerabend C, Russell MA. Improved gas chromatographic method and micro-extraction technique for the measurement of nicotine in biological fluids. J Pharm Pharmacol. 1979;31(2):73–6.PubMedCrossRef

30.

Butts WC, Kuehneman M, Widdowson GM. Automated method for determining serum thiocyanate to distinguish smokers from non-smokers. Clin Chem. 1974;20:1344–8.PubMed

31.

Kraemer MJ, Richardson MA, Weiss NS, et al. Risk factors for persistent middle-ear effusions. Otitis media, catarrh, cigarette smoke exposure, and atopy. JAMA. 1983;249:1022–5.PubMedCrossRef

32.

Blakley BW, Blakley JE. Smoking and middle ear disease: are they related? A review article. Otolaryngol Head Neck Surg. 1995;112:441–6.PubMedCrossRef

33.

Gulya AJ. Environmental tobacco smoke and otitis media. Otolaryngol Head Neck Surg. 1994;111:6–8.PubMed

34.

Strachan DP, Cook DG. Health effects of passive smoking: 4-Parental smoking, middle ear disease and adenotonsillectomy in children. Thorax. 1998;53:50–6.PubMedCrossRef

35.

Ilicali OC, Keles N, Deger K, et al. Evaluation of the effect of passive smoking on otitis media in children by and objective method: urinary cotinine analysis. Laryngoscope. 2001;111:163–7.PubMedCrossRef

36.

Health Effects of Exposure to Environmental Tobacco Smoke: The report of the California environmental protection agency. Smoking and tobacco control monograph no. 10. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1999.

37.

The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Rockville, MD, US Department of Health and Human Services, Centers for Disease Control and Prevention; 2006.

38.

•• Hawkins SS, Berkman L. Increased tobacco exposure in older children and its effect on asthma and ear infections. J Adolesc Health 2011; 48(6):647–50. This study emphasises that adolescants are increasingly exposed to SHS than younger children, which may increase adolescents’ vulnerability to ear infections. PubMedCrossRef

39.

Colman GJ, Joyce T. Trends in smoking before, during and after pregnancy in ten states. Am J Prev Med. 2003;24:29–35.PubMedCrossRef

40.

Kum-Nji P, Meloy L, Herrod HG. Environmental tobacco smoke exposure: prevalence and mechanisms of causation of infections in children. Pediatrics. 2006;117:1745–54.PubMedCrossRef

41.

Stathis SL, O’Callaghan DM, Williams GM, et al. Maternal cigarette smoking during pregnancy is an independent predictor for symptoms of middle ear disease at five years’ postdelivery. Pediatrics. 1999;104:e16.PubMedCrossRef

42.

Lieu JEC, Feinstein AR. Effect of gestational and passive smoke exposure on ear infections in children. Arch Pediatr Adolesc Med. 2002;156:147–54.PubMed

43.

• Håberg SE, Bentdal YE, London SJ, et al. Pre- and postnatal parental smoking and acute otitis media in early childhood. Acta Paediatr. 2010; 99(1):99–105. This study supports earlier findings of increased occurrence of AOM in children exposed to tobacco smoke in early life in a society with low levels of exposure and high parental awareness. PubMed

44.

•• Jones LL, Hassanien A, Cook DG. Parental smoking and the risk of middle ear disease in children: a systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2011; Sep 5. These authors provide an excellent review and a sytematic meta-analysis of sixty-one epidemiological studies.

45.

Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax. 1994;49:825–34.PubMedCrossRef

46.

Marcy TW, Merrill WW. Cigarette smoking and respiratory tract infection. Clin Chest Med. 1987;8:381–91.PubMed

47.

Richardson MA. Upper airway complications of cigarette smoking. J Allergy Clin Immunol. 1988;81:1032–5.PubMedCrossRef

48.

Noble RC, Penny BB. Comparison of leukocyte count and function in smoking and nonsmoking young men. Infect Immun. 1975;12:550–5.PubMed

49.

Corberand J, Nguyen F, Do AH, et al. Effect of tobacco smoking on the functions of polymorphonuclear leukocytes. Infect Immun. 1979;23:577–81.PubMed

50.

Eichel B, Shahrik HA. Tobacco smoke toxicity: loss of human oral leukocyte function and fluidcell metabolism. Science. 1969;166:1424–8.PubMedCrossRef

51.

Pabst MJ, Pabst KM, Collier JA, et al. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol. 1995;66:1047–55.PubMed

52.

Numabe Y, Ogawa T, Kamoi H, et al. Phagocytic function of salivary PMN after smoking or secondary smoking. Ann Periodontol. 1998;3:102–7.PubMedCrossRef

53.

Hasseus B, Wallstrom M, Osterdahl BG, et al. Immunotoxic effects of smokeless tobacco on the accessory cell function of rat oral epithelium. Eur J Oral Sci. 1997;105:45–51.PubMedCrossRef

54.

Raman AS, Swinburne AJ, Fedullo AJ. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest. 1983;83:23–7.PubMedCrossRef

55.

Fainstein V, Musher D. Bacterial adherence to pharyngeal cells in smokers, nonsmokers and chronic bronchitics. Infect Immun. 1979;26:178–82.PubMed

56.

Sopori ML, Kozak W, Savage SM, et al. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology. 1998;23:189–204.PubMedCrossRef

57.

Babu KS, Arshad SH. The role of allergy in the development of airway inflammation in children. Paediatr Respir Rev. 2003;4:40–6.PubMedCrossRef

58.

Zhang S, Petro TM. The effect of nicotine on murine CD4 T cell responses. Int J Immunopharmacol. 1996;18:467–78.PubMedCrossRef

59.

Holt PG. Immune and inflammatory function in cigarette smokers. Thorax. 1987;42:241–9.PubMedCrossRef

60.

Castellazzi AM, Maccario R, Moretta A, et al. Effect of active and passive smoking during pregnancy on natural killer-cell activity in infants. J Allergy Clin Immunol. 1999;103:172–3.PubMedCrossRef

61.

Murphy TF. Otitis media, bacterial colonization and the smoking parent. Clin Infect Dis. 2006;42:904–6.PubMedCrossRef

62.

Harabuchi Y, Faden H, Yamanaka N, et al. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. J Infect Dis. 1994;170:862–6.PubMedCrossRef

63.

Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.PubMedCrossRef

64.

Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis. 1997;175:1440–5.PubMedCrossRef

65.

Brook I, Gober AE. Recovery of potential pathogens and interfering bacteria in the nasopharynx of smokers and nonsmokers. Chest. 2005;127:2072–5.PubMedCrossRef

66.

Greenberg D, Givon-Lavi N, Broides A, et al. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis. 2006;42:897–903.PubMedCrossRef

67.

Brook I, Gober AE. Recovery of potential pathogens in the nasopharynx of healthy and otitis media-prone children and their smoking and nonsmoking parents. Ann Otol Rhinol Laryngol. 2008;117(10):727–30.PubMed

68.

Brook I, Gober AE. Effect of smoking cessation on the microbial flora. Arch Otolaryngol Head Neck Surg. 2007;133:135–8.PubMedCrossRef

69.

El Ahmer OR, Essery SD, Saadi AT, et al. The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol. 1999;23:27–36.PubMedCrossRef

70.

Stanley PJ, Wilson R, Greenstone MA, et al. Effect of cigarette smoking on nasal mucociliary clearance andciliary beat frequency. Thorax. 1986;41:519–23.PubMedCrossRef

71.

Merrill WW, Goodenberger D, Strober W, et al. Free secretory component and other proteins in human lung lavage. Am Rev Respir Dis. 1980;122:156–61.PubMed

72.

Tos M, Bak-Pedersen K. Density of goblet cells in chronic secretory otitis media: findings in a biopsy material. Laryngoscope. 1975;85:377–83.PubMedCrossRef

73.

Giebink GS, Le CT, Paparella MM. Epidemiology of otitis media with effusion in children. Arch Otolaryngol. 1982;108:563–6.PubMedCrossRef

74.

Kawano H, Paparella MM, Ho SB, et al. Identification of MUC5B mucin gene in human middle ear with chronic otitis media. Laryngoscope. 2000;110:668–73.PubMedCrossRef

75.

Moon SK, Lim DJ, Lee HK, et al. Mucin gene expression in cultured human middle ear epithelial cells. Acta Otolaryngol. 2000;120:933–9.PubMedCrossRef

76.

• Preciado D, Lin J, Wuertz B, Rose M. Cigarette smoke activates NFκB and induces Muc5b expression in mouse middle ear cells. Laryngoscope 2008; 118(3):464–71. This study demonsrated that much as in lung cells, the activation of mucins by cigarette smoke is mediated by NF-κB in the mouse murine middle ear epithelial cells. PubMedCrossRef

77.

• Cho JG, Woo JS, Lee HM, et al. Effects of cigarette smoking on mucin production in human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol. 2009; 73(10):1447–51. This study demonsrated that application of cigarette smoke solution on human middle ear cell increased the expression of MUC5AC mRNAs and proteins which play a major role in OME. PubMedCrossRef

78.

• Committee on Environmental Health, Committee on Substance Abuse, Committee on Adolescence, and Committee on Native American Child Health. Tobacco use: A pediatric disease. Pediatrics 2009; 124:1474–87. These authors provide an excellent review on tobacco control strategies and the role of pediatricians in tobacco control.

79.

Fiore M, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008 update-clinical practice guideline. Rockville: US Department of Health and Human Services, Public Health Service; 2008.

80.

McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156–70.PubMedCrossRef

81.

Winickoff JP, Tanski SE, McMillen RC, et al. Child health care clinicians’ use of medications to help parents quit smoking: a national parent survey. Pediatrics. 2005;115:1013–7.PubMedCrossRef

82.

Potts LA, Garwood CL. Varenicline: the newest agent for smoking cessation. Am J Health Syst Pharm. 2007;64(13):1381–4.PubMedCrossRef

83.

Ladomenou F, Moschandreas J, Kafatos A, et al. Protective effect of exclusive breastfeeding against infections during infancy: a prospective study. Arch Dis Child. 2010;95(12):1004–8.PubMedCrossRef

84.

• Yilmaz G, Hızlı Ş, Karacan C, et al. Effects of passive smoking on growth and infection rates of breast-fed and non-breastfed infants. Pediatr Int. 2009; 51:352–8. This study demonsrated that breast-feeding promoted the growth of infants who were exposed to SHS and protected them against infections. PubMedCrossRef

85.

Quinn G, Ellison BB, Meade C, et al. Adapting smoking relapse-prevention materials for pregnant and postpartum women: formative research. Matern Child Health J. 2006;10:235–45.PubMedCrossRef

86.

Pulley KR, Flanders-Stepans MB. Smoking hygiene: an educational intervention to reduce respiratory symptoms in breastfeeding infants exposed to tobacco. J Perinat Educ. 2002;11(3):28–37.PubMed

87.

• Alpert HR, Behm I, Connolly GN, Kabir Z. Smoke-free households with children and decreasing rates of paediatric clinical encounters for otitis media in the United States. Tob Control 2011; 20(3):207–11. Authors used an ecological design to quantify trends and it was demonsrated that while percentages of homes with no-smoking rules increased and paediatric encounters for OM decreased. PubMedCrossRef

Title: Effects of Active and Passive Smoking on Ear Infections
Authors: Gonca Yilmaz
Nilgun Demirli Caylan
Can Demir Karacan
Publication date: 01-04-2012
Publisher: Current Science Inc.
Published in: Current Infectious Disease Reports / Issue 2/2012
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-012-0239-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

The Increased Risk of Community-Acquired Methicillin-Resistant Staphylococcus Aureus in Neck Infections in Young Children

Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management

Herpes Diagnostic Tests and Their Use

Emerging Sexual Health Issues Among Women Who Have Sex with Women

Dacryocystitis: Systematic Approach to Diagnosis and Therapy

Diagnosis and Management of Necrotizing Fasciitis of the Head and Neck

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials